Emily S. Ruiz

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

Neil D. Gross, David M. Miller, Nikhil I. Khushalani et al. · New England Journal of Medicine · 2022 · 288 citations · Full text

Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women’s Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma

Emily S. Ruiz, Pritesh S. Karia, Robert J. Besaw et al. · JAMA Dermatology · 2019 · 189 citations · Full text

Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer

Jenna H. Newman, Charles B. Chesson, Nora L. Herzog et al. · Proceedings of the National Academy of Sciences · 2019 · 185 citations · Full text

Incidence and mortality for cutaneous squamous cell carcinoma: comparison across three continents

Andreas Stang, Laura Khil, Hiltraud Kajüter et al. · Journal of the European Academy of Dermatology and Venereology · 2019 · 116 citations · Full text

Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study

Neil D. Gross, David M. Miller, Nikhil I. Khushalani et al. · The Lancet Oncology · 2023 · 90 citations

Surgical Oncology, Survival Outcomes, Neoadjuvant Cemiplimab +9